Guest: Joshua M. Bauml, MD 


 Tune in to hear medical oncologist Dr. Joshua Bauml from the University of Pennsylvania explain the difference between RET fusions and RET point mutations and how they each affect our treatment approach.

Guest: Joshua M. Bauml, MD Tune in to hear medical oncologist Dr. Joshua Bauml from the University of Pennsylvania explain the difference between RET fusions and RET point mutations and how they each affect our treatment approach.

RET Fusions vs. RET Point Mutations: Understanding the Difference

Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking.
In an effort to both address and resolve this disparity, Closing the Gaps in NSCLC will focus on the latest guidelines and the current therapeutic landscape within NSCLC.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.
 Sponsored by

Medicine

Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking. In an effort to both address and resolve this disparity, Closing the Gaps in NSCLC will focus on the latest guidelines and the current therapeutic landscape within NSCLC. This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only. Sponsored by

Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking.
In an effort to both address and resolve this disparity, Closing the Gaps in NSCLC will focus on the latest guidelines and the current therapeutic landscape within NSCLC.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.
&nbsp;Sponsored by

Share RET Fusions vs. RET Point Mutations: Understanding the Difference

Sign up to save your podcasts

RET Fusions vs. RET Point Mutations: Understanding the Difference

RET Fusions vs. RET Point Mutations: Understanding the Difference